Jessica Krakow

Jessica Krakow is a Senior Scientist at Maverick Therapeutics since August 2017, specializing in protein analytical chemistry and method development for proprietary T-cell redirecting protein therapeutics. Previous experience includes a Principal Scientist role at Genentech, focusing on monoclonal antibodies and antibody-drug conjugates, and multiple positions at Target Discovery, Inc. developing methods for cancer biomarker characterization. Early career roles involved significant contributions to projects in pharmaceutical development at companies like Elan Pharmaceuticals, Sequus Pharmaceuticals, and Metrika, with a solid educational foundation that includes a Ph.D. in biochemistry from The Johns Hopkins University School of Medicine.